Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 19, 2021

SELL
$232.09 - $256.88 $12.5 Million - $13.8 Million
-53,720 Closed
0 $0
Q4 2020

Feb 01, 2021

BUY
$221.92 - $245.94 $188,632 - $209,049
850 Added 1.61%
53,720 $13.4 Million
Q3 2020

Oct 20, 2020

BUY
$215.77 - $276.76 $44,664 - $57,289
207 Added 0.39%
52,870 $12.3 Million
Q2 2020

Jul 27, 2020

BUY
$219.9 - $263.41 $240,350 - $287,907
1,093 Added 2.12%
52,663 $12.6 Million
Q1 2020

Apr 27, 2020

SELL
$195.69 - $279.01 $52,836 - $75,332
-270 Reduced 0.52%
51,570 $11.8 Million
Q4 2019

Jan 22, 2020

BUY
$236.45 - $266.82 $29,083 - $32,818
123 Added 0.24%
51,840 $14.1 Million
Q3 2019

Oct 23, 2019

SELL
$230.58 - $256.08 $5.89 Million - $6.54 Million
-25,548 Reduced 33.07%
51,717 $13.1 Million
Q2 2019

Jul 24, 2019

BUY
$217.4 - $246.08 $176,528 - $199,816
812 Added 1.06%
77,265 $19.5 Million
Q1 2019

Apr 09, 2019

SELL
$206.05 - $248.17 $132,902 - $160,069
-645 Reduced 0.84%
76,453 $19.1 Million
Q4 2018

Jan 18, 2019

SELL
$204.73 - $257.93 $1.15 Million - $1.45 Million
-5,625 Reduced 6.8%
77,098 $17.4 Million
Q3 2018

Oct 15, 2018

SELL
$233.07 - $256.0 $415,796 - $456,704
-1,784 Reduced 2.11%
82,723 $21.6 Million
Q2 2018

Jul 25, 2018

BUY
$208.1 - $233.85 $1.42 Million - $1.6 Million
6,832 Added 8.8%
84,507 $20.2 Million
Q1 2018

Apr 25, 2018

BUY
$205.46 - $240.27 $412,563 - $482,462
2,008 Added 2.65%
77,675 $16.8 Million
Q4 2017

Jan 25, 2018

SELL
$189.0 - $222.64 $597,807 - $704,210
-3,163 Reduced 4.01%
75,667 $16.2 Million
Q3 2017

Oct 11, 2017

SELL
$186.89 - $198.9 $854,834 - $909,768
-4,574 Reduced 5.48%
78,830 $15.4 Million
Q2 2017

Aug 09, 2017

BUY
N/A
83,404
83,404 $16.3 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Campbell Newman Asset Management Inc Portfolio

Follow Campbell Newman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell Newman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Campbell Newman Asset Management Inc with notifications on news.